Non-Small Cell Lung Cancer

5 Notable Oncology FDA Approvals Granted in May: A B2B Analysis

FDA · oncology · 6 min

FDA clears U.S. trial of MAIA lung cancer drug for third-line patients

FDA · lung cancer · 6 min

Pharma bets on PD-1/VEGF bispecifics: Is lung cancer the wrong target?

FDA · non-small cell lung cancer · 5 min

Roche's Alecensa Secures Expanded Approval in Japan for ALK-Positive Lung Cancer

FDA · ALK Tumors · 9 min

Osimertinib FDA Approval Expands Early-Stage NSCLC Treatment

FDA · early-stage non-small cell lung cancer (NSCLC) adjuvant therapy · 6 min

Summit Therapeutics Ivonescimab Shows Overall Survival Benefit in Lung Cancer, ASCO 2026 Plenary Data Expected

Non-Small Cell Lung Cancer (NSCLC) · 3 min

KRAS G12C Inhibitors NSCLC: Market Analysis of Sotorasib & Adagrasib

FDA · oncology · 9 min

AACR 2026: AI Pathology & Oncolytic Virus Spark Interest

oncology · 8 min

FDA Approval KRAS G12C NSCLC: Sotorasib & Adagrasib Insights

FDA · oncology · 10 min

FDA Accelerated Approval of KRAS G12C Inhibitors in NSCLC: Sotorasib vs Adagrasib

FDA · oncology · 11 min

AACR 2024: Oncology News & Key Takeaways - Day 1

oncology · 12 min

Revolution Medicines Presents Updated Zoldonrasib Phase 1 Data for KRAS G12D Lung Cancer at AACR 2026

2 min